Matrix metalloproteinase-9 — Drug Target

All drugs that target Matrix metalloproteinase-9 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Alkylating Drug [EPC] · cefradine · cefonicid

Marketed (5)

• Busulfex · Waylis · Alkylating Drug [EPC] · Oncology
  Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death.
• Dtic-Dome · Bayer · Alkylating Drug [EPC] · Oncology
• busulfex · Dana-Farber Cancer Institute · Oncology
• Cefradex · Bristol-Myers Squibb · cefradine · Immunology
• Monocid · cefonicid · Immunology

Phase 2 pipeline (1)

• Busilvex · medac GmbH · Oncology